can type 1 diabetics take glp-1 Could GLP-1 Receptor Agonists Help Prevent Infections in GLP-1 Medications for Type 1
Description
Evidence: The prevalence of residual gastric content (RGC) is markedly elevated among GLP-1 RA usersobserved in 24% compared with 5% in matched controls [13], with a pooled odds ratio of 5.6 in meta-analysis [8]
added sugar), and so on
The Outlook for Pharmacy Revenues to 2030 12.3
The study shows that the relative risk increases are real, but the absolute number of men affected is still small
[1] It is not approved for treating type 2 diabetes, though its active ingredient tirzepatide is marketed separately as Mounjaro for that indication
